发明名称 USE OF MODULATOR OF COMPOUND OF TGF-&bgr; SUPERFAMILY TO REGULATE HEPCIDIN-MEDIATED IRON METABOLISM
摘要 <P>PROBLEM TO BE SOLVED: To provide new agents and methods for the prevention and treatment of iron metabolism disorders. <P>SOLUTION: The methods for regulating hepcidin expression or activity in a subject includes a step of administering to the subject an effective amount of a compound that modulates the signaling activity of at least one TGF-&beta; superfamily member, thereby regulating the hepcidin expression or activity in a subject. The compound is preferably an agent selected from the group consisting of an agonist of TGF-&beta;, an antagonist of TGF-&beta;, an agonist of BMP, an antagonist of BMP, and combinations thereof. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012126722(A) 申请公布日期 2012.07.05
申请号 JP20110264338 申请日期 2011.12.02
申请人 GENERAL HOSPITAL CORP 发明人 LIN HERBERT Y;BABITT JODIE;CHUNG RAYMOND T;SAMAD TAREK A;SCHNEYER ALAN L;WOOLF CLIFFORD
分类号 A61K45/00;A61K31/295;A61K31/7135;A61K33/26;A61K38/00;A61K39/395;A61P3/12;A61P7/06;A61P29/00;A61P31/04;A61P35/00;A61P37/06;A61P43/00;C07K14/47;C12N15/09;G01N33/15;G01N33/50;G01N33/53 主分类号 A61K45/00
代理机构 代理人
主权项
地址
您可能感兴趣的专利